RGEN - Company ID 0000730272
The table below shows REPLIGEN CORP's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $566.02M | $757.36M | $751.32M | $523.46M | $603.81M | $717.29M |
| Short-term investments | $201.61M | - | - | - | - | - |
| Receivables | $158.59M | $134.12M | $124.16M | $116.25M | $117.42M | $71.26M |
| Inventory | $170.46M | $142.96M | $202.32M | $238.28M | $184.49M | $95.03M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.14B |
| $1.07B |
| $1.11B |
| $998.12M |
| $931.68M |
| $902.38M |
| Property, plant & equipment | $186.61M | $197.74M | $207.44M | $190.67M | $124.96M | $66.87M |
| Goodwill | $1.11B | $1.03B | $987.12M | $855.51M | $860.36M | $618.30M |
| Total assets | $2.95B | $2.83B | $2.82B | $2.52B | $2.36B | $1.90B |
| Accounts payable | $30.01M | $32.13M | $19.56M | $27.55M | $36.20M | $16.88M |
| Total current liabilities | $135.83M | $126.79M | $158.16M | $404.20M | $375.26M | $318.96M |
| Long-term debt | $542.21M | - | - | - | - | - |
| Total liabilities | $843.57M | $856.95M | $866.34M | $613.96M | $608.29M | $373.74M |
| Retained earnings | $456.25M | $407.35M | $438.85M | $397.27M | $194.06M | $65.77M |
| Total equity | $2.11B | $1.97B | $1.96B | $1.91B | $1.75B | $1.53B |